Michael Hummel¹, Stefan Bentink^*2, Hilmar Berger^*3, Wolfram Klapper^*4, Swen Wessendorf^*5, Thomas F.E. Barth⁶, Heinz-Wolfram Bernd⁷, Sergio Cogliatti⁸, Judith Dierlamm⁹, Alfred C. Feller⁷, Martin-Leo Hansmann¹⁰, Eugenia Haralambieva¹¹, Lana Harder¹², Dirk Hasenclever³, Michael Kühn¹, Dido Lenze¹, Peter Lichter¹⁵, Jose Ignacio Martin-Subero¹², Peter Möller⁶, Hans-Konrad Müller-Hermelink¹¹, German Ott¹¹, Reza M. Parwaresch⁴, Christiane Pott¹³, Andreas Rosenwald¹¹, Maciej Rosolowski¹⁴, Carsten Schwaenen⁵, Benjamin Stürzenhofecker¹⁶, Monika Szczepanowski⁴, Heiko Trautmann¹³, Hans-Heinrich Wacker⁴, Rainer Spang², Markus Loeffler³, Lorenz Trümper¹⁶, Harald Stein^°1, Reiner Siebert¹² for the Deutsche Krebshilfe, Network Project "Molecular Mechanisms in Malignant Lymphomas"

^*: These authors contributed equally to this article.

Corresponding Author:
^°Harald Stein (MD)
Charité - Universitätsmedizin Berlin
Campus Benjamin Franklin, Institute of Pathology
Hindenburgdamm 30
D-12200 Berlin, Germany
Tel: +49 30 8445 2295
Fax: +49 30 8445 4473
E-mail: Harald.Stein@charite.de

Affiliations:

1. Institute of Pathology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Germany (Michael Hummel, Harald Stein, Dido Lenze, Michael Kühn);
2. Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Computational Diagnostics Group, Berlin, Germany (Stefan Bentink, Rainer Spang);
3. Institute for Medical Informatics, Statistics and Epidemiology, Universität Leipzig, Germany (Hilmar Berger, Dirk Hasenclever, Markus Loeffler);
4. Institute of Hematopathology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany (Wolfram Klapper, Reza M. Parwaresch, Monika Szcepanowski, Hans-Heinrich Wacker);
5. Cytogenetic and Molecular Diagnostics, Internal Medicine III, Universitätsklinikum Ulm, Germany (Carsten Schwaenen, Swen Wessendorf);
6. Institute of Pathology, Universitätsklinikum Ulm, Germany (Thomas FE Barth, Peter Möller);
7. Institute of Pathology Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Germany (Heinz-Wolfram Bernd, Alfred C. Feller);
8. Institute of Pathology, Kantonsspital St. Gallen, Switzerland (Sergio Cogliatti);
9. Department of Oncology and Hematology, Universitätsklinikum Hamburg-Eppendorf, Germany (Judith Dierlamm);
10. Institute of Pathology, Universitätsklinikum Frankfurt, Germany (Martin-Leo Hansmann);
11. Institute of Pathology, Universität Würzburg, Germany (German Ott, Andreas Rosenwald, Hans-Konrad Müller-Hermelink, Eugenia Haralambieva);
12. Institute of Human Genetics, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany (Reiner Siebert, Jose Ignacio Martin-Subero, Lana Harder);
13. Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Germany (Christiane Pott, Heiko Trautmann);
14. Interdisciplinary Center for Bioinformatics, Leipzig, Germany (Maciej Rosolowski);
15. German Cancer Research Center (DKFZ), Heidelberg, Germany (Peter Lichter);
16. Department for Hematology and Oncology, Georg-August Universität Göttingen, Germany (Benjamin Stürzenhofecker, Lorenz Trümper)